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Quality of life (QoL) of children and adolescents has
only recently received the attention it rightfully
deserves. Reviews of the effects of a number of the
most common chronic childhood conditions (1) show an
enormous diversity of impact and associated needs.
Before the introduction of QoL instruments, there was a
dearth of appropriate means for comparison across
conditions. The foremost advantage of QoL measure-
ments is that they can be used for evaluating core
dimensions associated with a life of quality, giving
direction and guidance in providing appropriate ser-
vices. Because it is still in its early stages, research on
QoL in children and adolescents has several serious
limitations.
First, there is poor agreement on the core quality of
life dimensions. While many speci c schemas have
been proposed, they, in fact, overlap considerably (2).
Second, most research on children used proxy
reports. We need to make a compelling argument for
the use of information obtained from youths them-
selves. Average correlations between biomedical tests
of disease parameters and patient reports of well-being
are fairly low, especially in children (3). Therefore, it is
not surprising that the ability of physicians and nurses
accurately to rate their patients’ QoL is limited. Both
under- and over-estimation of limitations, pain and
psychological impact occur (4). Moreover, we fre-
quently see a discrepancy between ef cacy of a
treatment from the provider’s and the patient’s point
of view. Similarly, ratings of behavioural and emotional
functioning by youths themselves tend to have a low
correlation with ratings by parents, teachers, or mental-
health workers (5, 6). Insights such as these have led to
the reasoning that QoL is best understood from the
perspective of the individual (7, 8). While this is well
acknowledged in the  eld of adult QoL research,
methods to obtain children’s and adolescents’ views
on their QoL are only beginning to be developed.
Third, the modus operandi has been to develop
setting- or condition-speci c QoL instruments, almost
for each separate research project or clinic. This
approach has made it virtually impossible to develop a
knowledge base on the impact of chronic conditions on
children or what are effective and ef cacious interven-
tions or policies for improving their QoL. We need to
move towards the adoption of a select few QoL
instruments that can be applied generically to summar-
ize information from children and adolescents as well as
their parents, caretakers and health providers. Of
course, we are interested in learning about disease
impact. However, QoL and disease impact are theore-
tically distinct concepts and need to be measured
separately.
The paper by Loonen et al. (9) in this issue of Acta
P~diatrica skilfully deals with a number of issues in
QoL assessment. It shows that adolescents with
in ammatory bowel disease (IBD), especially those
with Crohn’s disease, differ from their healthy peers in
body complaints, motor functioning, autonomy and
negative emotions. The study makes strong use of well-
developed and validated, truly health-related instru-
ments that ask about the emotional response to recent
health problems. The balanced conclusions re ect the
relative merits of generic and disease-speci c instru-
ments, which prove to be differentially sensitive to the
number of disease-related symptoms. By using both
generic and disease-speci c measures, the study also
shows that young people with chronic disease may
experience considerable disease impact, although with-
out reduced QoL on generic domains. If impact
measures only had been used, we would not know that
at least one-third of the young patients with IBD rate
their QoL optimal regarding motor functioning, cogni-
tive functioning, social functioning, positive emotions
and autonomy. It also shows that in general QoL is
mainly affected by severe symptomatology. Only by
using a generic measure, could the QoL of these patients
be compared with that of their age peers in the general
population.
Many instruments have been developed in a rela-
tively short period of time to measure QoL in young
people. This re ects the rapidly growing interest shown
over the past decade in the broad impact of health
conditions and interventions on young people’s lives,
mirroring, albeit in the typically delayed fashion, what
has transpired in adult populations. Spieth (10) reviews
some 17 generic QoL instruments in detail. However,
from this pool, it is dif cult to select a few speci c
instruments that are worthy of further consideration.
They were clearly developed for different purposes,
such as epidemiological surveys, policy and program
evaluation, and patient assessment. Those labelled by
Spieth as health pro les and multidimensional instru-
ments come closest to the conceptualization of QoL that
we would like to emphasize. Each instrument within
these two categories, however, has shortcomings, such
as being overly long, targeting only adolescents, or
requesting only self- or parent reporting. Nonetheless,
from among these instruments we recommend that
further consideration be given the RAND Health Status
Measure of Children (11), the Child Health Rating
Inventories (12), How Are You? (13), and Quality of
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Life Pro le (14), as well as the PedsQL (15) and the
TACQOL (16). None of these instruments is completely
satisfactory at present, but they all contain elements that
will serve as a good base for further work. In addition, a
large number of disease-speci c instruments have been
developed (1), many of which can be found at the
website: http://www.mapi-research-inst.com. In our
view, those instruments purported to be disease-speci c
QOL measures may be useful for measurement of the
more limited construct of perceived disease impact.
The common denominator of most of the applications
of the QoL notion is that QoL is viewed from a patient
group perspective. That is, the main focus has been on
how a speci c patient group can be described in terms
of needs and effects, to enable recommendations for
clinical care in that patient population. This use of QoL
should be helpful to evidence-based medicine, in which
systematized knowledge is collected on the effects of
treatment regimens. Likewise, QoL considerations
should inform managed care plans by providing
information about economic, yet effective use of
services. As detailed elsewhere (17) among others,
QoL measurements may be used to determine QoL
differences between different groups; to determine how
complications unrelated to disease activity affect QoL;
to determine whether condition-related differences exist
between different subgroups; to use in intervention
trials; to determine the association between childhood
QoL and other prognostic factors and outcome in
prospective studies; to assess the relationship between
medical and environmental support and QoL outcomes;
to assist in the allocation of resources and public policy
decision-making.
Some authors maintain that QOL research “will be
fully accepted by [healthcare] practitioners only when it
answers questions directly related to clinical programs
and therapeutic choices” (18). This re ects the limited
focus of QoL research in one of its major  elds of
application. Many would feel that separate attention to
QoL issues would be outside their circle of in uence
and competence. Many consider it unnecessary and not
useful to address QoL as an outcome of medical
treatment beyond disease impact. Many healthcare
providers are still unfamiliar with QoL concepts and
their measurement. This is certainly very different from
biomedical measures. In addition, there is considerable
disagreement on whether QoL is an appropriate goal for
healthcare. The lack of familiarity with QoL concepts
and psychosocial measurement as a whole is expressed
as scepticism against “subjective” data. There is also
resistance to the use of structured or standardized
formats to assess QoL as well as toward posing
“private” questions. Admittedly, before healthcare
providers are prepared to spend time and money on
QoL, there are numerous issues that have to be resolved.
These include a better de nition of the QoL domain and
its relevance for the practice of care, as well as the still
limited guidelines for care that can as yet be derived
from our current state of knowledge based on QoL. To
this end, combined research and practical efforts need to
address the issues mentioned in this commentary.
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